Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > EPS CONCENSUS 0.90 /// VALEANT CAME IN AT 1.04 ( HUGE BEAT )
View:
Post by johnnywick on Nov 08, 2017 9:23pm

EPS CONCENSUS 0.90 /// VALEANT CAME IN AT 1.04 ( HUGE BEAT )

Valeant coming goal is to cut debt down to $15-$20  billion ... don't forget our new top gun drugs for glucoma ... and Siliq ... and etc.,,


Valeant stock price also closing in on a technical breakout... OH YEAH !!
Comment by johnnywick on Nov 09, 2017 12:30am
Poor 69 chevelle .. got wasted by Valeant Spectacular Earnings
Comment by 69chevelleSS on Nov 09, 2017 12:14pm
Again you post imaginary stuff. I probably have more VRX than you do bud. I dont post on boards I dont own. Again you should reread the earnings report and not just the close notes. And then you wont post stuff that wasnt said anywhere even on the conference call.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities